Professor Neerja Bhatla (All India Institute of Medical Sciences, New Delhi, India) discusses her Article on the Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9–14 years versus an established quadrivalent HPV vaccine in women aged 15–26 years in India.

Read the full article:

https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00480-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanonc

Continue this conversation on social!

Follow us today at...

https://twitter.com/thelancet & https://Twitter.com/TheLancetOncol

https://instagram.com/thelancetgroup

https://facebook.com/thelancetmedicaljournal

https://linkedIn.com/company/the-lancet

https://youtube.com/thelancettv

Id. d’épisode : 1000636925232

GUID : Buzzsprout-14055905

Date de publication : 29/11/2023 à 15:00:00